Nicolas Tsapis

Citée par

	Toutes	Depuis 2020
Citations	9228	4379
indice h	53	33
indice i10	122	92

920

460

230

690

20052006200720082009201020112012201320142015201620172018201920202021202220232024202525 54 80 119 143 182 254 314 336 437 486 563 531 569 623 704 898 902 842 871 162

Accès public

Tout afficher

53 articles

4 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Elias FattalUniversité Paris-SaclayAdresse e-mail validée de universite-paris-saclay.fr
Julien NICOLASCNRS Research Director, Univ Paris-Saclay. Twitter: @julnicolasAdresse e-mail validée de universite-paris-saclay.fr
David A. WeitzProfessor of Physics and Applied Physics, Harvard UniversityAdresse e-mail validée de seas.harvard.edu
Julien ValetteCommissariat à l'Energie AtomiqueAdresse e-mail validée de cea.fr
Adam BohrNovo Nordisk - Oral Formulation ResearchAdresse e-mail validée de novonordisk.com
Anthony NovellPh.DAdresse e-mail validée de u-psud.fr
antoine andremontProfesseur de microbiology Université Paris Diderot, Paris, FranceAdresse e-mail validée de aphp.fr
Mathieu D. SantinParis Brain Institute (ICM), Center For NeuroImaging Research (CENIR)Adresse e-mail validée de icm-institute.org
Silvia GuterresUniversidade Federal do Rio Grande do SulAdresse e-mail validée de ufrgs.br
Adriana Raffin PohlmannProfessora do Programa de Pós graduação em Ciências Farmacêuticas da Faculdade de FarmáciaAdresse e-mail validée de ufrgs.br
John W. HutchinsonSchool of Engineering and Applied Sciences, Harvard UniversityAdresse e-mail validée de husm.harvard.edu
L MahadevanHarvard, Cambridge, MITAdresse e-mail validée de seas.harvard.edu
Eric R. DufresneCornell UniversityAdresse e-mail validée de cornell.edu
Moritz Beck-BroichsitterMerck KGaAAdresse e-mail validée de merckgroup.com
Jean-Michel EscoffreiBraiN Deputy Director | Group Leader - Ultrasound: Imaging & TherapyAdresse e-mail validée de inserm.fr
Ayache BouakazInsermAdresse e-mail validée de univ-tours.fr
Julien FlamentMIRCen - CEA/, Fontenay-aux-Roses, FranceAdresse e-mail validée de cea.fr
Charles PeloquinProfessor of Pharmacy, University of FloridaAdresse e-mail validée de cop.ufl.edu
franco alhaiqueAdresse e-mail validée de uniroma1.it
Prof. Alban LE MONNIERInstitut Micalis, UMR1319 Université Paris-Saclay, INRAE, AgroParisTech, équipe 21 BaPSAdresse e-mail validée de universite-paris-saclay.fr

Suivre

Nicolas Tsapis

Université Paris-Saclay, Institut Galien Paris-Saclay, UMR CNRS 8612

Adresse e-mail validée de universite-paris-saclay.fr

Nanotechnologies pour la santé/Nanotechnologies for health


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Trojan particles: large porous carriers of nanoparticles for drug delivery N Tsapis, D Bennett, B Jackson, DA Weitz, DA Edwards Proceedings of the National Academy of Sciences 99 (19), 12001-12005, 2002	694	2002
Pickering emulsions: Preparation processes, key parameters governing their properties and potential for pharmaceutical applications C Albert, M Beladjine, N Tsapis, E Fattal, F Agnely, N Huang Journal of Controlled Release 309, 302-332, 2019	424	2019
Onset of buckling in drying droplets of colloidal suspensions N Tsapis, ER Dufresne, SS Sinha, CS Riera, JW Hutchinson, ... Physical review letters 94 (1), 018302, 2005	384	2005
Thermoresponsive polymer nanocarriers for biomedical applications A Bordat, T Boissenot, J Nicolas, N Tsapis Advanced drug delivery reviews 138, 167-192, 2019	383	2019
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles C Gómez-Gaete, N Tsapis, M Besnard, A Bochot, E Fattal International journal of pharmaceutics 331 (2), 153-159, 2007	333	2007
Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications T Boissenot, A Bordat, E Fattal, N Tsapis Journal of Controlled Release 241, 144-163, 2016	269	2016
Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells S Mura, H Hillaireau, J Nicolas, B Le Droumaguet, C Gueutin, S Zanna, ... International journal of nanomedicine, 2591-2605, 2011	238	2011
Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization E Pisani, N Tsapis, J Paris, V Nicolas, L Cattel, E Fattal Langmuir 22 (9), 4397-4402, 2006	222	2006
Pulmonary drug delivery systems for tuberculosis treatment DD Pham, E Fattal, N Tsapis International journal of pharmaceutics 478 (2), 517-529, 2015	210	2015
Liquid Perfluorocarbons as Contrast Agents for Ultrasonography and ¹⁹F-MRI R Díaz-López, N Tsapis, E Fattal Pharmaceutical research 27 (1), 1-16, 2010	191	2010
Hyaluronic acid-coated liposomes for active targeting of gemcitabine S Arpicco, C Lerda, E Dalla Pozza, C Costanzo, N Tsapis, B Stella, ... European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 373-380, 2013	168	2013
Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging E Pisani, N Tsapis, B Galaz, M Santin, R Berti, N Taulier, E Kurtisovski, ... Advanced Functional Materials 18 (19), 2963-2971, 2008	163	2008
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages N Grabowski, H Hillaireau, J Vergnaud, N Tsapis, M Pallardy, ... International journal of pharmaceutics 482 (1-2), 75-83, 2015	149	2015
Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells N Grabowski, H Hillaireau, J Vergnaud, LA Santiago, S Kerdine-Romer, ... International journal of pharmaceutics 454 (2), 686-694, 2013	147	2013
Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells S Mura, H Hillaireau, J Nicolas, S Kerdine-Römer, B Le Droumaguet, ... Biomacromolecules 12 (11), 4136-4143, 2011	143	2011
Control of particle morphology in the spray drying of colloidal suspensions E Lintingre, F Lequeux, L Talini, N Tsapis Soft Matter 12 (36), 7435-7444, 2016	136	2016
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent R Díaz-López, N Tsapis, M Santin, SL Bridal, V Nicolas, D Jaillard, ... Biomaterials 31 (7), 1723-1731, 2010	131	2010
Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor AD Wojcicki, H Hillaireau, TL Nascimento, S Arpicco, M Taverna, S Ribes, ... Journal of controlled release 162 (3), 545-552, 2012	121	2012
Sustained release of nanosized complexes of polyethylenimine and anti-TGF-β2 oligonucleotide improves the outcome of glaucoma surgery ALG dos Santos, A Bochot, A Doyle, N Tsapis, J Siepmann, F Siepmann, ... Journal of controlled release 112 (3), 369-381, 2006	116	2006
Compositions for sustained action product delivery and methods of use thereof D Edwards, R Batycky, J Schmitke, N Tsapis, D Weitz, J Hrkach US Patent App. 10/300,070, 2003	116	2003

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs